May 3 (Reuters) - Emergent BioSolutions Inc:
* EMERGENT BIOSOLUTIONS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* Q1 ADJUSTED LOSS PER SHARE $0.03
* Q1 LOSS PER SHARE $0.10
* Q1 REVENUE $117.8 MILLION VERSUS I/B/E/S VIEW $140.4 MILLION
* SEES Q2 2018 REVENUE $205 MILLION TO $230 MILLION
* Q1 EARNINGS PER SHARE VIEW $0.22 -- THOMSON REUTERS I/B/E/S
* REAFFIRMS FULL YEAR 2018 FINANCIAL FORECAST AND OPERATIONAL GOALS
* Q2 REVENUE VIEW $170.4 MILLION -- THOMSON REUTERS I/B/E/S
* FY2018 EARNINGS PER SHARE VIEW $2.38, REVENUE VIEW $731.4 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.